Chronic Lymphocytic Leukemia | Topics

TG Therapeutics Initiates BLA for Ublituximab Combo to Treat CLL
December 02, 2020

The company expects to complete the rolling submission of its biologics license application for ublituximab in combination with umbralisib in the first half of 2021.

FDA Clears clonoSEQ Assay to Evaluate MRD in Patients with CLL
August 07, 2020

The FDA cleared the clonoSEQ assay to detect and monitor minimal residual disease in blood or bone marrow from patients with chronic lymphocytic leukemia.

Matthew Steven Davids, MD, MMSc, on the Venetoclax, R-EPOCH Combo for Richter’s Syndrome
July 26, 2020

The CLL expert spoke about the implications of this study for patients and how patients can apply this knowledge to their own course of treatment.